AU3079692A - Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections - Google Patents
Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infectionsInfo
- Publication number
- AU3079692A AU3079692A AU30796/92A AU3079692A AU3079692A AU 3079692 A AU3079692 A AU 3079692A AU 30796/92 A AU30796/92 A AU 30796/92A AU 3079692 A AU3079692 A AU 3079692A AU 3079692 A AU3079692 A AU 3079692A
- Authority
- AU
- Australia
- Prior art keywords
- propylamines
- naphthyloxy
- hydroxy
- viral infections
- cell immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH3795/91 | 1991-12-20 | ||
CH379591 | 1991-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3079692A true AU3079692A (en) | 1993-07-28 |
Family
ID=4263624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU30796/92A Abandoned AU3079692A (en) | 1991-12-20 | 1992-12-14 | Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0587823A1 (en) |
AU (1) | AU3079692A (en) |
CA (1) | CA2109224A1 (en) |
FI (1) | FI935056A0 (en) |
WO (1) | WO1993013049A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013761A (en) * | 1988-06-03 | 1991-05-07 | Eli Lilly And Company | Serotonin antagonists |
GB0023467D0 (en) * | 2000-09-25 | 2000-11-08 | Btg Int Ltd | Amine compounds |
CN107556203B (en) * | 2016-06-30 | 2022-05-03 | 康普药业股份有限公司 | Preparation method of propranolol |
CN113336656B (en) * | 2021-05-28 | 2022-03-01 | 常州康普药业有限公司 | Method for synthesizing propranolol hydrochloride |
US11998013B1 (en) | 2023-09-01 | 2024-06-04 | King Faisal University | 1-(morpholin-4-yl)-3-(naphthalen-2-yloxy)propan-2-ol as an eco-friendly insecticidal agent against spodoptera littoralis (boisd.) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4026897A (en) * | 1974-01-31 | 1977-05-31 | Otsuka Pharmaceutical Company | 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives |
US4329502A (en) * | 1978-08-28 | 1982-05-11 | Syva Company | Propranolol antigen conjugates and antibodies |
DE3066975D1 (en) * | 1980-08-04 | 1984-04-19 | Syva Co | Propranolol antigen conjugates and antibodies and method of using them |
US4652681A (en) * | 1982-04-15 | 1987-03-24 | Drug Science Foundation | Aminoalkoxy derivatives of propranolol for immunoassay applications |
US4472301A (en) * | 1982-05-27 | 1984-09-18 | Miles Laboratories, Inc. | Propranolol immunogen and antibodies |
PT87163B (en) * | 1987-04-09 | 1992-07-31 | Lilly Co Eli | 1-PHENYL-3-NAFTALENYLXY-PROPANAMINES PREPARATION |
-
1992
- 1992-12-14 AU AU30796/92A patent/AU3079692A/en not_active Abandoned
- 1992-12-14 WO PCT/CH1992/000242 patent/WO1993013049A1/en not_active Application Discontinuation
- 1992-12-14 EP EP19920924530 patent/EP0587823A1/en not_active Withdrawn
- 1992-12-14 CA CA 2109224 patent/CA2109224A1/en not_active Abandoned
-
1993
- 1993-11-15 FI FI935056A patent/FI935056A0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1993013049A1 (en) | 1993-07-08 |
FI935056A0 (en) | 1993-11-15 |
EP0587823A1 (en) | 1994-03-23 |
CA2109224A1 (en) | 1993-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6194094A (en) | Sweetener, process for the preparation thereof and the use thereof | |
EP0600470A3 (en) | Bipolar membrane. | |
EP0584245A4 (en) | Enzyme systems. | |
AU2231488A (en) | Composition suitable for use as, or in, an acidic rinse aid | |
AU9075591A (en) | N-halochitosans, their preparation and uses | |
AU1704588A (en) | Amino-9,10-secosteroids | |
AU2056792A (en) | Means for the conveyance of produce, particularly fruit | |
AU1454188A (en) | 3-substituted 1-(2-chlorothiazol-5-yl-methyl)-2-nitroimino- 1,3-diazacycloalkanes | |
GR3025747T3 (en) | Device for the culture of molluses, in particular of oysters. | |
IL109963A0 (en) | E2-f1 enzyme and methods for the isolation, purification and use thereof | |
AU620688B2 (en) | Aseptically-packaged, aspartame-containing puddings | |
AU3999785A (en) | Laminates, particularly mirror laminates | |
AU1738192A (en) | LFA-3-like protein, derivatives thereof, genes thereof and processes for preparing the same | |
AU5922694A (en) | 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use | |
AU4511489A (en) | 14alpha,17alpha-ethano-estratrienes | |
AU3079692A (en) | Using the immunoactivating activity of 3-naphthyloxy-2-hydroxy-propylamines, in particular for providing cell immunity, e.g. against viral infections | |
AU1959488A (en) | (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin | |
EP0646342A3 (en) | Chair. | |
AU566917B2 (en) | 5-oxo-2,4-dichloro-4-substituted pentanenitriles | |
AU2353092A (en) | Substituted aminopropanes, processes for their preparation, and their use | |
AU1059692A (en) | Membranes | |
AU2406684A (en) | Hexanor-brassinolidine-22-ethers, i.e. 6-or7-oxa-b- homosteroids | |
AU6191086A (en) | Dispenser, in particular for milk or the like | |
AU3205893A (en) | New 4-cinnolinyl- and 4-naphthyridinyl-dihydropyridines, processes for their use in medicaments | |
AU1517888A (en) | Des-19-leucine, 20-glutamine, 21-threonine, 22-tyrosine-calcitonin |